PD-L1-Expressing Radiation-Associated Angiosarcoma after Primary Breast Cancer
Radiation-associated angiosarcoma (RAAS) is a type of radiation-associated sarcoma (RAS) that develops at the previous field of radiation in breast cancer patients. Although several reports have suggested a poor prognosis for RAAS, the 5-year overall survival of RAAS is better than that of cutaneous...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006628/ https://www.ncbi.nlm.nih.gov/pubmed/29928212 http://dx.doi.org/10.1159/000489628 |
_version_ | 1783332873427746816 |
---|---|
author | Takeda, Kana Fujimura, Taku Lyu, Chunbing Tsukada, Akira Tsuchiyama, Kenichiro Hashimoto, Akira Aiba, Setsuya |
author_facet | Takeda, Kana Fujimura, Taku Lyu, Chunbing Tsukada, Akira Tsuchiyama, Kenichiro Hashimoto, Akira Aiba, Setsuya |
author_sort | Takeda, Kana |
collection | PubMed |
description | Radiation-associated angiosarcoma (RAAS) is a type of radiation-associated sarcoma (RAS) that develops at the previous field of radiation in breast cancer patients. Although several reports have suggested a poor prognosis for RAAS, the 5-year overall survival of RAAS is better than that of cutaneous angiosarcoma (CAS), suggesting that the prognostic factors of RAAS and CAS might be different, at least in part. In this report, we describe a case of RAAS, and employed immunohistochemical (IHC) staining of PD-L1 and MMP9 as well as periostin, IL-4, and CD163. Interestingly, IHC staining revealed that the RAAS in our case was positive for PD-L1 and negative for MMP9. Moreover, the predominant stromal factor of our case was periostin, suggesting that TAMs in the present case was not immunosuppressive, but an inflammatory subtype. These results might explain, at least in part, the better prognosis of RAAS compared to CAS. |
format | Online Article Text |
id | pubmed-6006628 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-60066282018-06-20 PD-L1-Expressing Radiation-Associated Angiosarcoma after Primary Breast Cancer Takeda, Kana Fujimura, Taku Lyu, Chunbing Tsukada, Akira Tsuchiyama, Kenichiro Hashimoto, Akira Aiba, Setsuya Case Rep Oncol Case Report Radiation-associated angiosarcoma (RAAS) is a type of radiation-associated sarcoma (RAS) that develops at the previous field of radiation in breast cancer patients. Although several reports have suggested a poor prognosis for RAAS, the 5-year overall survival of RAAS is better than that of cutaneous angiosarcoma (CAS), suggesting that the prognostic factors of RAAS and CAS might be different, at least in part. In this report, we describe a case of RAAS, and employed immunohistochemical (IHC) staining of PD-L1 and MMP9 as well as periostin, IL-4, and CD163. Interestingly, IHC staining revealed that the RAAS in our case was positive for PD-L1 and negative for MMP9. Moreover, the predominant stromal factor of our case was periostin, suggesting that TAMs in the present case was not immunosuppressive, but an inflammatory subtype. These results might explain, at least in part, the better prognosis of RAAS compared to CAS. S. Karger AG 2018-05-29 /pmc/articles/PMC6006628/ /pubmed/29928212 http://dx.doi.org/10.1159/000489628 Text en Copyright © 2018 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission. |
spellingShingle | Case Report Takeda, Kana Fujimura, Taku Lyu, Chunbing Tsukada, Akira Tsuchiyama, Kenichiro Hashimoto, Akira Aiba, Setsuya PD-L1-Expressing Radiation-Associated Angiosarcoma after Primary Breast Cancer |
title | PD-L1-Expressing Radiation-Associated Angiosarcoma after Primary Breast Cancer |
title_full | PD-L1-Expressing Radiation-Associated Angiosarcoma after Primary Breast Cancer |
title_fullStr | PD-L1-Expressing Radiation-Associated Angiosarcoma after Primary Breast Cancer |
title_full_unstemmed | PD-L1-Expressing Radiation-Associated Angiosarcoma after Primary Breast Cancer |
title_short | PD-L1-Expressing Radiation-Associated Angiosarcoma after Primary Breast Cancer |
title_sort | pd-l1-expressing radiation-associated angiosarcoma after primary breast cancer |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006628/ https://www.ncbi.nlm.nih.gov/pubmed/29928212 http://dx.doi.org/10.1159/000489628 |
work_keys_str_mv | AT takedakana pdl1expressingradiationassociatedangiosarcomaafterprimarybreastcancer AT fujimurataku pdl1expressingradiationassociatedangiosarcomaafterprimarybreastcancer AT lyuchunbing pdl1expressingradiationassociatedangiosarcomaafterprimarybreastcancer AT tsukadaakira pdl1expressingradiationassociatedangiosarcomaafterprimarybreastcancer AT tsuchiyamakenichiro pdl1expressingradiationassociatedangiosarcomaafterprimarybreastcancer AT hashimotoakira pdl1expressingradiationassociatedangiosarcomaafterprimarybreastcancer AT aibasetsuya pdl1expressingradiationassociatedangiosarcomaafterprimarybreastcancer |